These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 107515
1. [Epidemiological and clinical aspects of drug-resistant tubercle bacilli in children treated in the years 1961--1976]. Robakiewicz M, Paszkowska A, Szczukowa W. Pneumonol Pol; 1979 Feb; 47(2):107-16. PubMed ID: 107515 [No Abstract] [Full Text] [Related]
4. [Studies on infection by drug-resistant tubercle bacilli. 2. Primary drug resistance in children]. Osato T, Kihara K, Iwasaki T, Shimao T, Fukushima K. Kekkaku; 1968 Oct; 43(10):431-6. PubMed ID: 4974634 [No Abstract] [Full Text] [Related]
5. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3]. Nakai H, Maekawa N, Nakanishi M, Kawai M, Naito M. Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481 [No Abstract] [Full Text] [Related]
6. [Secondary drug sensitivity of tubercle bacilli in chronic sputum-positive tuberculosis patients]. Telejko Z. Gruzlica; 1970 Oct; 38(11):1101-4. PubMed ID: 4992233 [No Abstract] [Full Text] [Related]
7. Drug resistance in patients with pulmonary tuberculosis. Cheung OT. Can Med Assoc J; 1975 Nov 08; 113(9):848-9. PubMed ID: 810238 [Abstract] [Full Text] [Related]
8. [Resistance of Mycobacterium tuberculosis to the major antitubercular drugs in pulmonary tuberculosis in children and youth previously untreated]. Mordyński K, Piotrowski Z, Szymański A. Gruzlica; 1968 Aug 08; 36(8):715-8. PubMed ID: 4972465 [No Abstract] [Full Text] [Related]
10. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis]. Zierski M. Tuberkuloza; 1966 Aug 08; 18(1-3):300-6. PubMed ID: 16296101 [No Abstract] [Full Text] [Related]
13. [Clinical aspects of secondary resistance in pulmonary tuberculosis]. Gugić B. Plucne Bolesti; 1985 Aug 08; 37(1-2):22-7. PubMed ID: 3934690 [No Abstract] [Full Text] [Related]
14. [A comparison of the time of in vivo resistance development of tubercle bacilli to rifampicin, kanamycin, ethionamide, lividomycin, and enviomycin (tuberactinomycin-N) in patients with chronic cavitary tuberculosis (author's transl)]. Tsukamura M. Kekkaku; 1978 Oct 08; 53(10):495-8. PubMed ID: 102861 [No Abstract] [Full Text] [Related]
15. [Advances in the treatment of pulmonary tuberculosis in children]. Alcaide Megias J, Altet Gómez MN. An Esp Pediatr; 1983 Sep 08; 19 Suppl 19():12-7. PubMed ID: 6419658 [No Abstract] [Full Text] [Related]
16. [Prognostic value of isolation of drug-resistant Mycobacterium tuberculosis]. Astionenko AA. Vrach Delo; 1978 Dec 08; (12):27-30. PubMed ID: 105475 [No Abstract] [Full Text] [Related]
17. A 10 year survey on Mycobacterium tuberculosis isolates in Israel and their drug resistance. Lavy A, Mates A. Isr J Med Sci; 1994 Nov 08; 30(11):805-10. PubMed ID: 7982768 [Abstract] [Full Text] [Related]
18. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria]. Fomicheva NI, Terentieva AS. Probl Tuberk; 1981 Dec 08; (12):23-6. PubMed ID: 6801645 [No Abstract] [Full Text] [Related]
19. [Epidemiologic aspects of resistance to ATA (Antitubercular Agents)]. Zrilić V, Muzikravić T. Plucne Bolesti Tuberk; 1974 Dec 08; 26 Suppl 2():29-37. PubMed ID: 4216919 [No Abstract] [Full Text] [Related]
20. [Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)]. Rudoĭ NM. Probl Tuberk; 1974 Dec 08; (10):1-6. PubMed ID: 4213757 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]